[OKDXA] Fw: Lice Drug Slashes COVID Death Risk

Wed Jan 6 13:49:24 EST 2021

>From the NIH...  NOT APPROVED!  Usage would require administration of doses
up to 100-fold higher than those approved for use in humans.
https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/ivermectin/

73

-Steve.
NE5SD

-----Original Message-----
From: okdxa-bounces at mailman.qth.net <okdxa-bounces at mailman.qth.net> On
Behalf Of D C _Mac_ Macdonald
Sent: Wednesday, January 6, 2021 9:23 AM
To: OKDXA Mail List <okdxa at mailman.qth.net>
Subject: [OKDXA] Fw: Lice Drug Slashes COVID Death Risk

(Study: Ivermectin May Slash the Risk of Death for Hospitalized COVID-19
Patents by 80% |
Newsmax.com<https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2
Fwww.newsmax.com%2Fhealth%2Fhealth-news%2Fcoronavirus-invermectin-risk-death
%2F2021%2F01%2F04%2Fid%2F1004129%2F%3Fns_mail_uid%3De68533d3-2fea-471f-a4c7-
a65371375566%26ns_mail_job%3DDM180599_01062021%26s%3Dacs%26dkt_nbr%3D010502e
bu5u9&data=04%7C01%7C%7C69200539b64148a4e27908d8b2507b8a%7C84df9e7fe9f640afb
435aaaaaaaaaaaa%7C1%7C0%7C637455406022996742%7CUnknown%7CTWFpbGZsb3d8eyJWIjo
iMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=vf7
ToHar2qSgcCzWnp7SRidvhF7jaQ7PJzl93csjGBc%3D&reserved=0>)

Study: Ivermectin May Slash the Risk of Death for Hospitalized COVID-19
Patients by 80%

By Lynn Allison    |   Monday, 04 January 2021 10:56 AM

A study to be released next month found that Ivermectin, an inexpensive drug
used to treat head lice, could be a potentially effective tool in the
COVID-19 battle.  According to the results of 11 trials involving 1,400
patients, researchers said eight of the 573 COVID-19 patients who received
Ivermectin died, compared to 44 of the 510 who got placebos.

According to the Daily
Mail<https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.da
ilymail.co.uk%2Fnews%2Farticle-9110301%2FCheap-hair-lice-drug-cut-risk-hospi
talised-Covid-patients-dying-80-study-finds.html&data=04%7C01%7C%7C69200539b
64148a4e27908d8b2507b8a%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C6374554
06022996742%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJB
TiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=RdymGP9SujW6CZDoI4pAU2GF0dN0b6MXn5gU
7PfDGL0%3D&reserved=0>, the observational studies revealed that the
prescription-only drug appeared to accelerate the removal of the virus from
the body.  Ivermectin is used to fight parasites like lice and scabies and
is also used in a skin cream to treat rosacea.  It's also used in the
veterinary world to treat intestinal organisms such as hookworms and
roundworms.

Dr. Andrew Hill, of the Pharmacology Department of Liverpool University, who
is a leading expert in HIV, analyzed the data and said the drug could be
"transformational" in the treating COVID-19.

Dr. Jean-Jacques Rajter, of Florida's Broward Health Medical Center recently
told Newsmax
TV<https://na01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.newsm
ax.com%2Flive&data=04%7C01%7C%7C69200539b64148a4e27908d8b2507b8a%7C84df9e7fe
9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637455406023006698%7CUnknown%7CTWFpbGZsb3d
8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&s
data=MrbmqtMcdgyEVJgSujegKcNncBYr0x4yyXz6U5I3D24%3D&reserved=0> that
scientific trials suggest that Ivermectin could be useful in treating the
coronavirus.

Rajter was one of seven researchers from the Broward Health Medical Center
who, after learning of Ivermectin's success in prohibiting replication of
the SARS-CoV-2 virus in a laboratory, reviewed 280 cases of patients with
COVID-19 who were - and were not treated - with Ivermectin.  Their results
were published in October in the medical journal
Chestnet.<https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fj
ournal.chestnet.org%2Farticle%2FS0012-3692(20)34898-4%2Fpdf&data=04%7C01%7C%
7C69200539b64148a4e27908d8b2507b8a%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C
0%7C637455406023006698%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV
2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=Z4ExYLqxAnlQ3sN7Y9g8uqtTi
clWTMR5wRlMjEkV76o%3D&reserved=0>

Patients
<https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.newsma
x.com%2Fus%2Fcovid-19-veterinary-drug-mortality%2F2020%2F10%2F13%2Fid%2F9917
90%2F&data=04%7C01%7C%7C69200539b64148a4e27908d8b2507b8a%7C84df9e7fe9f640afb
435aaaaaaaaaaaa%7C1%7C0%7C637455406023016650%7CUnknown%7CTWFpbGZsb3d8eyJWIjo
iMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=AK1
EplE03CS6tVI%2FXbrM4tL6XCBOstggdk3B2OxRJDc%3D&reserved=0> who received
Ivermectin had a mortality rate of 15% compared to 25% who did not receive
the drug.  The results were even more significant for COVID-19 patients with
"severe pulmonary involvement."

The mortality rate was only 38% for those patients who received Ivermectin
compared with 80.7% for the patients that did not receive it.

According to the Daily Mail, scientists believe that Ivermectin works by
paralyzing SARS-CoV-2, the virus that causes COVID-19, and "overwhelming its
nervous system" to prevent replication.  However, other scientists said they
were skeptical about the findings and suggested that more studies are needed
before including Ivermectin in the COVID-19 medical toolbox.

Upcoming trials of the drug including more than 7,000 volunteers are
expected to be published in the next few months.

"If we see these same trends observed consistently across more studies than
this is really going to be a transformational treatment," said Hill,
according to the Daily Mail.

The U.S. Food and Drug Administration issued an
alert<https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.d
rugs.com%2Ffda-alerts%2F1407-0.html&data=04%7C01%7C%7C69200539b64148a4e27908
d8b2507b8a%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637455406023016650%7
CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiL
CJXVCI6Mn0%3D%7C1000&sdata=f4pXbnIrceogxQiHfdMYgfaVXO8Wn0IP6jP0lwPKFu4%3D&re
served=0> to consumers who may self-medicate by taking Ivermectin products
that are not prescribed by a licensed health care provider and obtained from
a legitimate source.

______________________________________________________________
OKDXA mailing list
Home: http://mailman.qth.net/mailman/listinfo/okdxa
Help: http://mailman.qth.net/mmfaq.htm
Post: mailto:OKDXA at mailman.qth.net

This list hosted by: http://www.qsl.net
Please help support this email list: http://www.qsl.net/donate.html